LEONOR MARÍA
LAREDO VELASCO
Profesora asociada de Ciencias de la Salud
Instituto de Investigación Sanitaria Biodonostia
San Sebastián, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Biodonostia (1)
2022
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340